Clinical Trial Update: Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ONCOXIN in oral mucositis, appetite, and body mass in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis in Cancer Patients

Drugs mentioned

• ONCOXIN

Snippet

Sponsor: Catalysis SL | Conditions: Mucositis Oral | Phase 2 | Status: COMPLETED